Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.5B | 1.4B | 1.5B | 1.5B |
Cost of revenue | 1.3B | 1.2B | 1.3B | 1.3B |
Gross profit | 182M | 201M | 188M | 234M |
Operating expense | ||||
Research & development | 33M | 32M | 30M | 27M |
Selling general and admin | 160M | 166M | 166M | 153M |
Other operating expenses | -15M | -7M | 48M | 7M |
Operating income | 4M | 10M | -56M | 47M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 21M | 19M | 19M | 21M |
Other income expense | -122M | 36M | -6M | 8M |
Pretax income | -139M | 27M | -81M | 34M |
Tax provision | 7M | 15M | 29M | 39M |
Net income | -145M | 11M | -125M | -17M |
Basic EPS | -0.9 | 0.0 | -0.8 | -0.2 |
Diluted EPS | -0.9 | 0.0 | -0.8 | -0.2 |
Basic average shares | 173M | 172M | 172M | 172M |
Diluted average shares | 173M | 172M | 172M | 172M |
EBITDA | 78M | 83M | 20M | 130M |
Net income from continuing op. | -146M | 12M | -110M | -5M |
Minority interests | -13M | -16M | -16M | -16M |
Preferred stock dividends | — | — | — | — |